This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Zwerner, P. L. Articles by Gore, J. M. Search for Related Content PubMed Articles by Zwerner, P. L. Articles by Gore, J. M. Social Bookmarking                         What's this?

Analytic Review: Thrombolytic Therapy in Acute Myocardial Infarction

Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, MA 01605

Joel M. Gore, MD

Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester, MA 01605

The salvage of myocardium in the setting of acute myocardial infarction has long been a goal of physicians involved in the care of patients with coronary artery disease. Understanding the role of thrombosis in the pathogenesis of acute myocardial infarction has led the way to an entirely new approach to the treatment of this entity. Thrombolytic therapy has now become a widely used form of treatment with encouraging results. Both intravenous and intracoronary administration of thrombolytic agents have been shown to promote recanalization of acutely occluded coronary arteries. Results of studies using the clot-specific agent, tissue plasminogen activator, intravenously have been most encouraging; successful reperfusion has been obtained in approximately 70% of patients treated. In addition, a recent large-scale trial has shown a reduction in morbidity and mortality with the early use of thrombolytic agents.

Ongoing trials should help delineate the precise role and timing of these agents as the initial form of therapy for acute myocardial infarction. Other issues that remain unresolved are the frequency of restenosis and the role of percutaneous transluminal coronary angioplasty in addition to thrombolytic therapy in the treatment of acute myocardial infarction.

Journal of Intensive Care Medicine, Vol. 1, No. 6, 302-318 (1986)
DOI: 10.1177/088506668600100602


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E. Passamani Thrombolysis in Acute Myocardial Infarction J Intensive Care Med, December 1, 1986; 1(6): 299 - 301. [PDF]